• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.

作者信息

Maillart Elisabeth, Todesco Eve, Assoumou Lambert, Beigneux Ysoline, Lubetzki Catherine, Papeix Caroline, De Paz Raphael, Dubessy Anne-Laure, Djebara Siham, Louapre Céline, Pourcher Valérie

机构信息

Department of Neurology, AP-HP, Hôpital Pitié-Salpêtrière, Multiple Sclerosis Center, Paris, France.

Department of Virology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.

出版信息

J Neurol. 2024 May;271(5):2871-2874. doi: 10.1007/s00415-023-12175-2. Epub 2024 Jan 11.

DOI:10.1007/s00415-023-12175-2
PMID:38212430
Abstract
摘要

相似文献

1
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.抗CD20治疗前多发性硬化症患者乙肝疫苗加速接种后的体液免疫反应
J Neurol. 2024 May;271(5):2871-2874. doi: 10.1007/s00415-023-12175-2. Epub 2024 Jan 11.
2
[Anti-hepatitis B vaccination and postvaccinal immunity stimulation in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者的乙型肝炎疫苗接种及接种后免疫刺激]
Vopr Virusol. 2015;60(6):9-14.
3
Metronomic radiological surveillance in clinically stable MS patients on anti CD20 immunotherapy is redundant.对于接受抗CD20免疫治疗且临床病情稳定的多发性硬化症患者，进行节律性放射学监测是多余的。
Mult Scler Relat Disord. 2024 May;85:105541. doi: 10.1016/j.msard.2024.105541. Epub 2024 Mar 6.
4
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.抗 CD20 治疗的多发性硬化症患者接种 SARS-CoV-2 mRNA 疫苗后的细胞和体液免疫反应。
Nat Med. 2021 Nov;27(11):1990-2001. doi: 10.1038/s41591-021-01507-2. Epub 2021 Sep 14.
5
COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies.7 例接受抗 CD20 治疗的多发性硬化症患者合并 COVID-19。
Mult Scler Relat Disord. 2020 Sep;44:102306. doi: 10.1016/j.msard.2020.102306. Epub 2020 Jun 15.
6
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis.多发性硬化症患者疾病修正治疗和抗 CD20 输注时机与对 2 种 SARS-CoV-2 疫苗的体液免疫反应的关联。
JAMA Neurol. 2021 Dec 1;78(12):1529-1531. doi: 10.1001/jamaneurol.2021.3609.
7
A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.一种新型的靶向树突状细胞的乙肝DNA疫苗可诱导T细胞和体液免疫反应，并增强乙肝病毒转基因小鼠的抗病毒活性。
Immunol Lett. 2015 Dec;168(2):293-9. doi: 10.1016/j.imlet.2015.10.007. Epub 2015 Oct 21.
8
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis.多发性硬化症抗CD20疗法的分子与药理学特性的临床视角
CNS Drugs. 2021 Sep;35(9):985-997. doi: 10.1007/s40263-021-00843-8. Epub 2021 Aug 9.
9
Therapies for multiple sclerosis targeting B cells.针对B细胞的多发性硬化症治疗方法。
Croat Med J. 2019 Apr 30;60(2):87-98. doi: 10.3325/cmj.2019.60.87.
10
Long-term effectiveness of accelerated hepatitis B vaccination schedule in drug users.加速乙肝疫苗接种方案在吸毒者中的长期有效性
Am J Public Health. 2015 Jun;105(6):e36-43. doi: 10.2105/AJPH.2014.302487. Epub 2015 Apr 16.

引用本文的文献

1
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS.开始抗CD20治疗前疫苗接种剂量对多发性硬化症患者乙肝病毒血清保护率的影响。
Neurology. 2025 Feb 11;104(3):e210281. doi: 10.1212/WNL.0000000000210281. Epub 2025 Jan 16.

本文引用的文献

1
Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders?在患有多发性硬化症或相关疾病的患者中，改用抗CD20疗法后，对SARS-CoV-2的疫苗反应是否仍能保持？
J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):19-28. doi: 10.1136/jnnp-2023-331770.
2
HBV and VZV seroprotection loss in MS patients under DMT.接受疾病修正治疗的多发性硬化症患者中乙肝病毒和水痘-带状疱疹病毒血清保护作用的丧失
Mult Scler Relat Disord. 2023 Feb;70:104490. doi: 10.1016/j.msard.2022.104490. Epub 2022 Dec 28.
3
Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study.
多发性硬化症治疗中疾病修饰疗法的乙型肝炎病毒预防管理：一项意大利多中心回顾性研究。
J Neurol. 2022 Jun;269(6):3301-3307. doi: 10.1007/s00415-022-11009-x. Epub 2022 Feb 14.
4
Determining the best window for BNT162b2 mRNA vaccination for SARS-CoV-2 in patients with multiple sclerosis receiving anti-CD20 therapy.确定接受抗CD20治疗的多发性硬化症患者接种BNT162b2 mRNA新冠疫苗的最佳时间窗。
Mult Scler J Exp Transl Clin. 2021 Nov 29;7(4):20552173211062142. doi: 10.1177/20552173211062142. eCollection 2021 Oct.
5
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.多种疾病修饰疗法治疗的多发性硬化症患者对 COVID mRNA 疫苗的体液免疫反应特征。
Vaccine. 2021 Oct 1;39(41):6111-6116. doi: 10.1016/j.vaccine.2021.08.078. Epub 2021 Sep 2.
6
Seroconversion rate following HBV vaccination in clinical practice: The role of age and DMT treatment.临床实践中 HBV 疫苗接种后的血清转换率：年龄和 DMT 治疗的作用。
Mult Scler Relat Disord. 2021 May;50:102859. doi: 10.1016/j.msard.2021.102859. Epub 2021 Feb 23.
7
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis.奥瑞珠单抗治疗多发性硬化症后出现具有免疫逃逸突变的乙型肝炎病毒再激活
Open Forum Infect Dis. 2018 Dec 26;6(1):ofy356. doi: 10.1093/ofid/ofy356. eCollection 2019 Jan.
8
[Hepatitis B vaccination: a review].[乙肝疫苗接种：综述]
Med Sci (Paris). 2015 May;31(5):551-8. doi: 10.1051/medsci/20153105018. Epub 2015 Jun 9.
9
Vaccines to prevent viral hepatitis.预防病毒性肝炎的疫苗。
N Engl J Med. 1997 Jan 16;336(3):196-204. doi: 10.1056/NEJM199701163360307.